Structure–activity relationships of 1,3,5-triazine-2,4,6-triones as human gonadotropin-releasing hormone receptor antagonists
摘要:
SAR studies of 1, 3,5-triazine-2,4,6-triones as human gonadotropin-releasing hormone receptor antagonists resulted in potent compounds. The best compound from the series had a binding affinity of 2 nM. (c) 2005 Elsevier Ltd. All rights reserved.
DOI:
10.1016/j.bmcl.2005.05.038
作为产物:
描述:
2,6-二氟苄胺 、 3-甲氧基苯异氰酸 在
二氯甲烷 、 CI 作用下,
以
二氯甲烷 为溶剂,
反应 1.0h,
以to give a white solid (1.47 g, 50.3%), MS (CI) m/z 293.0 (MH+)的产率得到1-(2,6-difluorobenzyl)-3-(3-methoxyphenyl)urea
参考文献:
名称:
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
A convenient one-pot synthesis of asymmetric 1,3,5-triazine-2,4,6-triones and its application towards a novel class of gonadotropin-releasing hormone receptor antagonists
作者:Zhiqiang Guo、Dongpei Wu、Yun-Fei Zhu、Fabio C. Tucci、Joseph Pontillo、John Saunders、Qiu Xie、R. Scott Struthers、Chen Chen
DOI:10.1016/j.bmcl.2004.11.026
日期:2005.2
A convenient one-pot synthetic route was developed for the preparation of asymmetric 1,3-dialkyl-1,3,5-triazine-2,4,6-triones from readily available alkyl- or aryl-isocyanates, primary amines and N-chlorocarbonyl isocyanate in excellent yields. Subsequent alkylation with N-protected amino alcohols afforded the desired 1, 3,5 -triazine-2,4,6-triones in good yields. This methodology was applied to the synthesis of a chemical library acting as antagonists of the hGnRH receptor. (C) 2004 Elsevier Ltd. All rights reserved.
1,3,5-TRIAZINE-2,4,6-TRIONES, PREPARATION AND USE AS GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS
申请人:Neurocrine Biosciences, Inc.
公开号:EP1412338A1
公开(公告)日:2004-04-28
US6677340B2
申请人:——
公开号:US6677340B2
公开(公告)日:2004-01-13
[EN] 1,3,5-TRIAZINE-2,4,6-TRIONES, PREPARATION AND USE AS GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS<br/>[FR] 1,3,5-TRIAZINE-2,4,6-TRIONES, PREPARATION ET UTILISATION DE CES DERNIERS EN TANT QU'ANTAGONISTES DU RECEPTEUR DE LA GONADOLIBERINE
申请人:NEUROCRINE BIOSCIENCES INC
公开号:WO2003011839A1
公开(公告)日:2003-02-13
GnRH receptor antagonists of formula I are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.